Health Privacy

About health privacy, World Privacy Forum key health privacy resources

The World Privacy Forum is extremely active in health privacy, with a long and successful track record of work in this area. We have done groundbreaking work in the area of medical identity theft, as well as substantive analysis and education on critical privacy aspects of health data such as medical research, genomics, and many other issues. 

Some of our most frequently accessed health privacy resources include:

* A Patient’s Guide to HIPAA

* Medical Identity Theft Page (resources, reports, more)

* Health privacy tagged materials 

* HIPAA tagged materials 

* Electronic Health Records tagged materials 

* Common Rule and Human Subject Research Protection tagged materials

* Genetic privacy tagged materials 

We have many more publications and resources. For a full list of topics and publications, see our key issues page.

See below for health privacy news and content by date.

CVS Caremark pharmacy chain agrees to pay $2.25 million to settle charges of HIPAA violations; also settles with the FTC

Medical privacy | HIPAA | FTC — According to a legal complaint, CVS pharmacies — the largest pharmacy chain in the United States — did not take appropriate steps to protect its customers’ and employees’ sensitive information when it improperly disposed of documents, labels, prescription bottles, and other items with clearly identifiable and highly sensitive personal information such as SSNs, prescription information, driver’s license numbers, and other information still on those materials. CVS agreed to pay $2.25 million to settle its violations of HIPAA as part of a Resolution Agreement with the Department of Health and Human Services. CVS has also signed a consent agreement with the FTC; the public can comment on this agreement until March 20, 2009. The World Privacy Forum will be filing comments with the FTC on the consent agreement with CVS, which we will post here.

Keep my genes private: World Congress panel presentation

Genetic privacy — The World Privacy Forum presented a talk at the World Congress in Washington D.C. today on the intersection between genetic privacy and marketing, and on genetic issues and medical identity theft. The presentation exposed the list marketing activities surrounding health care data, and examined how the current loopholes in the recently passed Genetic Information Nondiscrimination Act (GINA) would not necessarily ease issues with incidental collection and use of genetic information.

World Privacy Forum elected to HITSP board

HITSP — World Privacy Forum executive director Pam Dixon was elected to be the consumer representative on the HITSP board (Health Information Technology Standards Panel). HITSP is a national standards-setting body that is part of ANSI (The American National Standards Institute) and is working on specifications and standards for the National Health Information Network. The term will begin in January of 2009.

World Privacy Forum Publishes Red Flag Rule Suggestions for Hospitals and Providers; new FTC-enforced rules go into effect Nov. 1, can apply to health care providers

SAN DIEGO, Ca., Sept. 24 — The World Privacy Forum’s latest report, Red Flag and Address Discrepancy Requirements: Suggestions for Health Care Providers, discusses the applicability of the new FTC regulations to the health care sector along with suggestions for providers. The report addresses newly issued regulations by the Federal Trade Commission that require financial institutions and creditors to develop and implement written identity theft prevention programs. Health care providers – whether they are for-profit, non-profit, or governmental entities – may have obligations under the new rules.

Public Comments: September 2008 – World Privacy Forum urges more attention to the protection of research study participants

Human Subjects Research Protection (OHRP) — The World Privacy Forum filed comments with the Office of Human Research Protection urging the office to do more to protect the privacy of people who are subjects of research. The comments urge the OHRP to focus more attention on providing privacy-specific training for boards overseeing research, which are often weak in knowledge about the breadth of privacy issues in research. The WPF also voiced its strong support for certificates of confidentiality for research involving human subjects, stating that “nearly all research that involves identifiable health data or other personal data about individuals should have a certificate of confidentiality unless a researcher can state a substantive reason why a certificate is not appropriate for the study.”